Basit öğe kaydını göster

dc.contributor.authorZhao, Ge
dc.contributor.authorZaidi, Tanweer S.
dc.contributor.authorZaidi, Tauqeer H.
dc.contributor.authorLederer, James A.
dc.contributor.authorPriebe, Gregory P.
dc.contributor.authorPier, Gerald B.
dc.contributor.authorBozkurt-Guzel, Cagla
dc.date.accessioned2021-03-05T21:28:22Z
dc.date.available2021-03-05T21:28:22Z
dc.date.issued2016
dc.identifier.citationZhao G., Zaidi T. S. , Bozkurt-Guzel C., Zaidi T. H. , Lederer J. A. , Priebe G. P. , Pier G. B. , "Efficacy of Antibody to PNAG Against Keratitis Caused by Fungal Pathogens", INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, cilt.57, ss.6797-6804, 2016
dc.identifier.issn0146-0404
dc.identifier.othervv_1032021
dc.identifier.otherav_d90882ca-1592-4027-92de-c3a02f508ba2
dc.identifier.urihttp://hdl.handle.net/20.500.12627/143177
dc.identifier.urihttps://doi.org/10.1167/iovs.16-20358
dc.description.abstractPURPOSE. Developing immunotherapies for fungal eye infections is a high priority. We analyzed fungal pathogens for expression of the surface polysaccharide, poly-N-acetyl glucosamine (PNAG), and used a mouse model of ocular keratitis caused by Aspergillus flavus, A. fumigatus, or Fusarium solani to determine if PNAG was an immunotherapy target and requirements for ancillary cellular and molecular immune effectors.
dc.language.isoeng
dc.subjectOFTALMOLOJİ
dc.subjectGöz Hastalıkları ve Cerrahisi
dc.subjectCerrahi Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.titleEfficacy of Antibody to PNAG Against Keratitis Caused by Fungal Pathogens
dc.typeMakale
dc.relation.journalINVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
dc.contributor.departmentHarvard University , ,
dc.identifier.volume57
dc.identifier.issue15
dc.identifier.startpage6797
dc.identifier.endpage6804
dc.contributor.firstauthorID86673


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster